chartexchange

Helus Pharma Reports Second Quarter Fiscal 2027 Financial Results and Recent Business Highlights

GlobeNewswire Inc. | Nov 16, 2026 6:00 AM EST

Appointed Michael Halstead as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization 

Read original article